Literature DB >> 4029216

First-pass metabolism of nomifensine in dogs.

R Lindberg, R Sellman, E Iisalo.   

Abstract

Nomifensine (1 and 5 mg/kg) was administered to dogs orally and intravenously. The pharmacokinetics of the drug was evaluated. Nomifensine was rapidly absorbed from the gastro-intestinal tract reaching maximum concentration at 0.5-1 h. The peak levels were directly proportional to the doses administered. The elimination half-life was 6 h and only very small amounts were found in blood at 24 h after administration. The apparent volume of distribution (Vd) was 120-149 1, suggesting an extensive distribution of the drug throughout body fluids and tissues. The area under the serum concentration-time curve (AUC) obtained after oral administration was significantly smaller than that after intravenous administration indicating incomplete bioavailability of the drug in oral form. The conjugation of nomifensine after the two different administration routes was also studied: the conjugation reaction was in equilibrium at 15 min after oral administration, while after intravenous administration, equilibrium was not reached until 1-1.5 h. The metabolism of nomifensine occurred in the gastrointestinal membranes and or in the liver during the absorption process; the first-pass effect was marked.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029216     DOI: 10.1007/BF03189693

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  18 in total

1.  Gas chromatographic method for the determination of nomifensine in human plasma.

Authors:  L Vereczkey; G Bianchetti; V Rovei; A Frigerio
Journal:  J Chromatogr       Date:  1976-01-21

2.  Metabolism of nomifensine in man and animal species.

Authors:  W Heptner; I Hornke; F Cavagna; H W Fehlhaber; W Rupp; H P Neubauer
Journal:  Arzneimittelforschung       Date:  1978

3.  Determination of nomifensine in human serum. A comparison of high-performance liquid and gas--liquid chromatography.

Authors:  R L Lindberg; J S Salonen; E I Iisalo
Journal:  J Chromatogr       Date:  1983-08-12

4.  First-pass metabolism of imipramine in man.

Authors:  L F Gram; J Christiansen
Journal:  Clin Pharmacol Ther       Date:  1975-05       Impact factor: 6.875

Review 5.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

6.  Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

7.  The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG.

Authors:  B Saletu; J Grünberger; L Linzmayer; K Taeuber
Journal:  Int Pharmacopsychiatry       Date:  1982

8.  Doxepin kinetics.

Authors:  V E Ziegler; J T Biggs; L T Wylie; S H Rosen; D J Hawf; W H Coryell
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

9.  First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma.

Authors:  G Alván; O Borga; M Lind; L Palmér; B Siwers
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

10.  Automated high-resolution gas chromatographic analysis of psychotropic drugs in biological fluids using open-tubular glass capillary columns. I. Determination of nomifensine in human plasma.

Authors:  E Bailey; M Fenoughty; L Richardson
Journal:  J Chromatogr       Date:  1977-01-21
View more
  1 in total

Review 1.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.